Based on PubMed | Do fish oil supplements improve blood sugar control in people with type 2 diabetes?

Most evidence suggests fish oil supplements do not meaningfully improve blood sugar control in people with type 2 diabetes, although they can lower triglycerides. ^[1] Across randomized trials and systematic reviews, omega‑3 fatty acids (EPA/DHA) generally show little to no effect on fasting glucose, insulin, or HbA1c, while consistently reducing triglycerides and sometimes modestly increasing LDL cholesterol. ^{[1] [2]}

What the research shows

• Glycemic control (glucose, HbA1c, insulin): Large pooled analyses of randomized controlled trials found no significant improvement in fasting glucose or insulin with marine omega‑3 supplementation in type 2 diabetes. ^[2] A broader meta‑analysis pooling 24 trials also found no beneficial effect on glycemia or insulinemia. ^[1]
  • One small 3‑month trial using purified EPA (2 g/day) reported reductions in fasting glucose, HbA1c, and HOMA‑IR versus placebo, but this finding has not been consistently reproduced across larger bodies of evidence. ^[3]
• Triglycerides and lipids: Marine omega‑3s reliably lower triglycerides (about 7% on average in pooled analyses), an effect that may be stronger at doses ≥2 g/day EPA/DHA. ^[1] However, LDL cholesterol may rise slightly (~3%) and HDL effects are inconsistent. ^{[1] [2]}
• Diabetes risk and omega‑3 intake: Prospective data do not show clear harm or benefit of fish/seafood or EPA+DHA intake on developing type 2 diabetes, while plant omega‑3 (ALA) may be linked to a modestly lower risk in some analyses, though not definitively. ^{[4] [5]}
• Insulin sensitivity: A meta‑analysis found no overall improvement in insulin sensitivity with omega‑3s; a HOMA subgroup suggested a small benefit, but this has not translated into consistent clinical changes in glucose control. ^[6]

Practical implications

• Not a glucose-lowering supplement: For most people with type 2 diabetes, fish oil (EPA/DHA) should not be expected to lower fasting glucose or HbA1c in a clinically meaningful way. ^{[1] [2]}
• Useful for high triglycerides: If triglycerides are elevated, omega‑3s can be helpful adjuncts; prescription-strength products are often used for this purpose and are generally considered safe, though LDL may rise slightly and bleeding risk can increase at higher doses or when combined with anticoagulants/antiplatelets. ^{[1] [7]}
• Food first approach: Eating fatty fish (such as salmon, mackerel, herring, sardines, trout) twice weekly is encouraged as part of a heart‑healthy diet, providing omega‑3s without the variability of supplements. ^{[8] [9]}

Safety and interactions

• Bleeding risk and blood pressure: Fish oil is generally safe, but high doses may increase bleeding risk, especially with blood thinners, and can slightly lower blood pressure, which may add to antihypertensive effects. ^[7]
• Common side effects: Gastrointestinal upset, fishy aftertaste, and burping are possible; taking with meals and using enteric‑coated products may help. (General safety guidance aligned with clinical monographs.) ^[7]

Bottom line

• Primary goal: If your goal is better blood sugar control, fish oil supplements are unlikely to help most users with type 2 diabetes, based on the best available randomized trial and meta‑analytic evidence. ^{[1] [2]}
• When to consider: They can be considered when triglycerides are high, weighing the small LDL increase and potential interactions. ^{[1] [7]}
• Best practice: Focus on proven strategies balanced nutrition, regular activity, weight management, and guideline‑directed glucose‑lowering medications while using omega‑3s primarily for triglyceride management and cardiovascular risk discussions with your clinician. ^[2]

---

Evidence snapshot

Outcome	Effect of fish oil (EPA/DHA) in T2D	Key notes
Fasting glucose	No meaningful change	Consistent across multiple RCT summaries. [2]
HbA1c	No meaningful change	One small EPA-only trial showed benefit; not consistent in larger evidence. [3] [2]
Fasting insulin / HOMA-IR	No consistent improvement	Meta‑analysis shows no overall effect; subgroup signals not definitive. [6]
Triglycerides	Decrease (~7% pooled)	Strongest, most consistent effect; larger reductions at higher doses. [1]
LDL cholesterol	Slight increase (~3%)	Monitor lipids; balance against triglyceride lowering. [1]
HDL cholesterol	No consistent change	Variable results across studies. [1] [2]

---

How to apply this

• If you’re considering fish oil primarily to manage blood sugar, it may be reasonable to prioritize other options with proven glycemic benefits and reserve omega‑3s for triglyceride reduction or dietary intake via fish. ^{[1] [2]}
• Discuss with your clinician if you have high triglycerides, are on blood thinners, or have bleeding risks, to decide on dose and formulation (EPA/DHA content, prescription vs. over‑the‑counter) and to monitor lipid changes over time. ^[7]